These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antibody and complement-mediated cytotoxicity for bovine parainfluenza-3 virus-infected cells. Hussain A; Mohanty SB Am J Vet Res; 1984 Jun; 45(6):1219-21. PubMed ID: 6331235 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of antibody-complement cytotoxicity against virus-transformed hamster PARA-7 cells treated with heat and microwave radiation. Cain CA; RamaRao GV; Tompkins WA Radiat Res; 1981 Oct; 88(1):96-107. PubMed ID: 6272345 [No Abstract] [Full Text] [Related]
6. Reactivities of mouse monoclonal antibody K2.7 to renal cancers in complement dependent cytotoxicity and antibody dependent cell-mediated cytotoxicity. Kinouchi T; Bander NH; Kotake T J Urol; 1995 Jul; 154(1):288-92. PubMed ID: 7776448 [TBL] [Abstract][Full Text] [Related]
7. Antibody- and complement-mediated cytolysis against duck-enteritis-virus-infected cells. Lam KM Avian Dis; 1984; 28(4):1125-9. PubMed ID: 6525133 [TBL] [Abstract][Full Text] [Related]
8. Effect of specific phospholipids on the antibody-complement-mediated killing of nucleated cells. Ohanian SH; Schlager SI; Yamazaki M; Ishida B J Immunol; 1979 Sep; 123(3):1014-9. PubMed ID: 469242 [No Abstract] [Full Text] [Related]
9. The usefullness of enzyme-labelled antibody method for ultrastructural localization of Newcastle disease virus antigens in infected Hela cells. Hoshino M; Maeno K J Electron Microsc (Tokyo); 1971; 20(1):49-55. PubMed ID: 5560032 [No Abstract] [Full Text] [Related]
10. Increased sensitivity of human leukemic granulocytes to heterophil antibody in normal rabbit sera. Bases R; Mendez F; Clark J; Rosenberg A; Milstein D J Natl Cancer Inst; 1970 May; 44(5):993-1000. PubMed ID: 5285265 [No Abstract] [Full Text] [Related]
11. Monocytotoxic antibodies in HIV-infected persons. TNF-alpha treatment of U937 cells increases the complement dependent cytotoxicity. Szabó B; Locardi C; Lo Presti E; Benedetto A; Belardelli F Acta Microbiol Hung; 1993; 40(3):191-200. PubMed ID: 8191865 [TBL] [Abstract][Full Text] [Related]
12. Complement-activating antibodies in sera from infected individuals and vaccinated volunteers that target human immunodeficiency virus type 1 to complement receptor type 1 (CR1, CD35). Zhou J; Montefiori DC Virology; 1996 Dec; 226(1):13-21. PubMed ID: 8941318 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of fusion from within by antiviral antibody in cells infected with Newcastle disease virus. Iinuma M; Maeno K; Nagura H; Matsumoto T Microbiol Immunol; 1979; 23(10):1037-41. PubMed ID: 514096 [No Abstract] [Full Text] [Related]
15. Studies on natural killer (NK) cells. I. NK cell specific antibodies in CE anti-CBA serum. Burton RC; Winn HJ J Immunol; 1981 May; 126(5):1985-9. PubMed ID: 7217676 [TBL] [Abstract][Full Text] [Related]
16. Schistosoma mansoni infection in humans and primates induces cytolytic antibodies to surface Le(x) determinants on myeloid cells. Nyame AK; Pilcher JB; Tsang VC; Cummings RD Exp Parasitol; 1996 Mar; 82(2):191-200. PubMed ID: 8617346 [TBL] [Abstract][Full Text] [Related]
18. [Sensitivity of HeLa cells continously infected with HVJ to other types of viruses]. Matsumoto T; Maeno K; Yoshii S; Nagata I Nihon Ishikai Zasshi; 1967 May; 57(10):1622-7. PubMed ID: 4294727 [No Abstract] [Full Text] [Related]
19. Evidence of a T-cell-mediated cytotoxic response to parainfluenza virus type 3 pneumonia in hamsters. Kimmel KA; Wyde PR; Glezen WP J Reticuloendothel Soc; 1982 Jan; 31(1):71-83. PubMed ID: 6278144 [No Abstract] [Full Text] [Related]
20. T-cell triggering by CD3- and CD28-binding molecules linked to a human virus-modified tumor cell vaccine. Haas C; Lulei M; Fournier P; Arnold A; Schirrmacher V Vaccine; 2005 Mar; 23(19):2439-53. PubMed ID: 15752830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]